Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Achieve Life Sciences (ACHV) Treasury Shares (2016 - 2026)

Achieve Life Sciences (ACHV) has disclosed Treasury Shares for 15 consecutive years, with $1.1 million as the latest value for Q1 2026.

  • Quarterly Treasury Shares fell 60.66% to $1.1 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $1.1 million through Mar 2026, down 60.66% year-over-year, with the annual reading at $1.1 million for FY2025, 15.53% down from the prior year.
  • Treasury Shares for Q1 2026 was $1.1 million at Achieve Life Sciences, roughly flat from $1.1 million in the prior quarter.
  • The five-year high for Treasury Shares was $2.8 million in Q1 2025, with the low at $252875.0 in Q4 2022.
  • Average Treasury Shares over 5 years is $1.2 million, with a median of $1.1 million recorded in 2025.
  • The sharpest move saw Treasury Shares skyrocketed 374.88% in 2022, then crashed 60.66% in 2026.
  • Achieve Life Sciences' Treasury Shares stood at $252875.0 in 2022, then soared by 100.84% to $507875.0 in 2023, then skyrocketed by 152.77% to $1.3 million in 2024, then dropped by 15.53% to $1.1 million in 2025, then changed by 0.0% to $1.1 million in 2026.
  • Per Business Quant, the three most recent readings for ACHV's Treasury Shares are $1.1 million (Q1 2026), $1.1 million (Q4 2025), and $1.1 million (Q3 2025).